MediPal Holdings Corporation
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MAHLY research report →
Companywww.medipal.co.jp
Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprises medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products. The company is also involved in the wholesale of cosmetics, daily necessities, and OTC pharmaceuticals; animal health products for companion animals; food processing raw materials for agriculture, fisheries, and livestock; and livestock feed additives, seasonings, veterinary medical equipment, packaging materials, industrial chemicals, and other products.
- CEO
- Shuichi Watanabe
- IPO
- 2009
- Employees
- 13,075
- HQ
- Tokyo, JP
Price Chart
Valuation
- Market Cap
- $3.89B
- P/E
- 13.54
- P/S
- 0.15
- P/B
- 0.88
- EV/EBITDA
- 3.58
- Div Yield
- 2.33%
Profitability
- Gross Margin
- 6.48%
- Op Margin
- 1.39%
- Net Margin
- 1.11%
- ROE
- 6.72%
- ROIC
- 4.04%
Growth & Income
- Revenue
- $4.05T · 10.25%
- Net Income
- $45.10B · 11.97%
- EPS
- $218.90 · 13.31%
- Op Income
- $56.39B
- FCF YoY
- -12.02%
Performance & Tape
- 52W High
- $20.35
- 52W Low
- $14.60
- 50D MA
- $18.71
- 200D MA
- $18.00
- Beta
- 0.09
- Avg Volume
- 45
Get TickerSpark's AI analysis on MAHLY
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our MAHLY Coverage
We haven't published any research on MAHLY yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate MAHLY Report →